NCT03445598 is a NA clinical trial of Interactive and personalized CCBT in Depressive Symptoms, sponsored by Indian Institute of Technology Kanpur.

Who is sponsoring NCT03445598?

NCT03445598 is sponsored by Indian Institute of Technology Kanpur.

What drugs are being tested in NCT03445598?

Interventions in NCT03445598: Interactive and personalized CCBT, Feature-limited CCBT, Waitlist control.

What condition does NCT03445598 study?

NCT03445598 studies Depressive Symptoms.

Is NCT03445598 still recruiting?

NCT03445598 is currently completed. Last updated 2 July 2019.

Last reviewed 2019-07-02 · How we verify

NCT03445598

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Automated and Personalized Cognitive Behavioral Therapy

Completed NA Last updated 2 July 2019

What this trial tests

NA trial testing Interactive and personalized CCBT in Depressive Symptoms in 600 participants. Completed in 31 May 2019.

Timeline

14 February 2018

Primary endpoint
2 March 2019

31 May 2019

Quick facts

Lead sponsor	Indian Institute of Technology Kanpur
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	supportive care
Enrollment	600
Start date	14 February 2018
Primary completion	2 March 2019
Estimated completion	31 May 2019
Sites	1 location across India

Drugs / interventions tested

Interactive and personalized CCBT
Feature-limited CCBT
Waitlist control

Conditions studied

Depressive Symptoms — all drugs for Depressive Symptoms →

Sponsor

Indian Institute of Technology Kanpur

Who can join

Adults 16 to 35, any sex, with Depressive Symptoms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is designed to evaluate a novel online tool to deliver computerized Cognitive Behavioral Therapy (CBT). Participants will be randomized into three groups: experimental, active control, and waitlist. Participants in the experimental group will have access to the full-featured online tool designed to deliver CBT in an interactive and personalized manner. The participants in the active control group will have access to a limited version of the online tool designed to deliver basic CBT in plain text format. The waitlisted participants will be put on a waitlist for 6 weeks. We hypothesize that the experimental group participants will show a significantly higher reduction in depression symptom severity and will show increased engagement and adherence to the online tool.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

An Unguided, Computerized Cognitive Behavioral Therapy Intervention (TreadWill) in a Lower Middle-Income Country: Pragmatic Randomized Controlled Trial.
Ghosh A, Cherian RJ, Wagle S, Sharma P, et al · · 2023 · cited 7× · PMID 37099376 · DOI 10.2196/41005

Verify or expand the search:

Other recruiting trials for Depressive Symptoms

Currently open trials in the same condition.

NCT07299903 — IMB-Based Sleep Hygiene Education for Menopausal Women: Effects on Sleep Quality and Depression · NA · recruiting
NCT07413692 — BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Urinary Incontinence in Postpartum and E · NA · recruiting
NCT07413705 — BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and · NA · recruiting
NCT07241325 — Psychological Well-Being, Depression, and Health-Related Quality of Life in Adults With Type 2 Diabetes: A Cross-Section · recruiting
NCT07216326 — Our Voices Matter: Intervention for Depression in Youth · NA · recruiting

Other Indian Institute of Technology Kanpur trials

Trials by the same sponsor.

NCT04308915 — Mobile-based Games for Cognitive Training in Children With Neurodevelopmental Disorders · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03445598 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Indian Institute of Technology Kanpur
Last refreshed: 2 July 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03445598.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing